PB2333: CAR-T CELL THERAPY IS A EXCELLENT STRATEGY FOR R/R B-NHL

• Liu Rui,
• Fan Yang,
• Fei Xue,
• Hui Shi,
• Peihao Zheng,
• Lixia MA,
• Shaomei Feng,
• Yuelu Guo,
• Teng Xu,
• Zhonghua Fu,
• Biping Deng,
• Xiaoyan Ke,
• Kai Hu

Affiliations

Liu Rui

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Fan Yang

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Fei Xue

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Hui Shi

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Peihao Zheng

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Lixia MA

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Shaomei Feng

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Yuelu Guo

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Teng Xu

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Zhonghua Fu

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Biping Deng

2 Beijing GoBroad Boren hospital, Cytology Laboratory, Beijing, China

Xiaoyan Ke

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China

Kai Hu

1 Beijing GoBroad Boren hospital, Department of Lymphoma and Myeloma Research Center, Beijing, China